학술논문

Biallelic PI4KA variants cause neurological, intestinal and immunological disease
Document Type
article
Source
Brain. 144(12)
Subject
Digestive Diseases
Pediatric
1.1 Normal biological development and functioning
Aetiology
2.1 Biological and endogenous factors
Underpinning research
Oral and gastrointestinal
Female
Hereditary Central Nervous System Demyelinating Diseases
Humans
Intestinal Atresia
Male
Minor Histocompatibility Antigens
Pedigree
Phosphotransferases (Alcohol Group Acceptor)
Polymorphism
Single Nucleotide
Primary Immunodeficiency Diseases
hypomyelinating leukodystrophy
multiple intestinal atresia
PI4KA
FAM126A
TTC7A
PI4KA
Medical and Health Sciences
Psychology and Cognitive Sciences
Neurology & Neurosurgery
Language
Abstract
Phosphatidylinositol 4-kinase IIIα (PI4KIIIα/PI4KA/OMIM:600286) is a lipid kinase generating phosphatidylinositol 4-phosphate (PI4P), a membrane phospholipid with critical roles in the physiology of multiple cell types. PI4KIIIα's role in PI4P generation requires its assembly into a heterotetrameric complex with EFR3, TTC7 and FAM126. Sequence alterations in two of these molecular partners, TTC7 (encoded by TTC7A or TCC7B) and FAM126, have been associated with a heterogeneous group of either neurological (FAM126A) or intestinal and immunological (TTC7A) conditions. Here we show that biallelic PI4KA sequence alterations in humans are associated with neurological disease, in particular hypomyelinating leukodystrophy. In addition, affected individuals may present with inflammatory bowel disease, multiple intestinal atresia and combined immunodeficiency. Our cellular, biochemical and structural modelling studies indicate that PI4KA-associated phenotypical outcomes probably stem from impairment of PI4KIIIα-TTC7-FAM126's organ-specific functions, due to defective catalytic activity or altered intra-complex functional interactions. Together, these data define PI4KA gene alteration as a cause of a variable phenotypical spectrum and provide fundamental new insight into the combinatorial biology of the PI4KIIIα-FAM126-TTC7-EFR3 molecular complex.